[OneMedForum] NuVue Therapeutics’ Multi-Step Approach to Cancer Therapy
NuVue Therapeutics is commercializing a site-specific regimen of cancer therapy for soft tissue tumors.
NuVue Therapeutics is commercializing a site-specific regimen of cancer therapy for soft tissue tumors.
HealthTronics announced that it has entered into a definitive merger agreement with Endocare.
Eight studies presented this week at the American Urological Association Annual Meeting suggest that Gen-Probe’s investigational test for the prostate cancer gene PCA3 may address some of the major challenges faced by urologists when diagnosing the disease.
Copyright © 2024 | WordPress Theme by MH Themes